Pakistan spoiled the talks by talking to Hurriyat: Sushma Swaraj

September 26, 2014

New York, Sep 26: External affairs minister Sushma Swaraj on Friday said Pakistan "spoiled the talks" by talking to Hurriyat leaders just ahead of foreign secretaries of the two nations were scheduled to meet in Islamabad last month.

Sushma Swaraj"New (Narendra Modi) government has given a new signal. So they (Pakistan) spoiled the talks, they spoiled the game," Swaraj told Indian reporters here after her meeting with the IBSA foreign ministers on the sidelines of the ongoing UN General Assembly session.

Swaraj was asked to comment on Pakistan's national security and foreign affairs adviser Sartaj Aziz's remarks that talks between the two countries can happen only if New Delhi takes the initiative since India was the one which cancelled the August 25 talks.

Swaraj said: "No question of first or second. As far as our reaction is concerned we have said repeatedly that if a reaction had to come it had to come at this time only. The initiative was there from our side," she said.

She said it was Prime Minister Narendra Modi who had invited Pakistani Prime Minister Nawaz Sharif for his swearing-in ceremony.

During the bilateral meeting between the two prime ministers, it was discussed that trade should start immediately at the Wagah-Attari border, said Swaraj.

She said Sharif had suggested that foreign secretaries should meet for bilateral talks and "we agreed to that."

"But just as the talks are about to happen on the 25th (August), four days prior to that the (Pakistani envoy) is talking with Hurriyat leaders, then who spoiled the game," she asked.

Aziz had also remarked that there was nothing new in Pakistani officials talking to Hurriyat leaders and such talks have been happening for the last 20 years.

Swaraj said as far as talks with Hurriyat leaders are concerned, the leaders who came from Pakistan used to talk with the group.

But "for the first time Prime Minister Nawaz Sharif came to India and he did not talk to them because he understood India's signal. Things began from there," she said.

"But before any talks, the ambassador has met with the Hurriyat leaders, that has never happened," Swaraj said.

Swaraj said she has not talked to Aziz yet but the two were present for the Commonwealth and SAARC foreign ministers' meetings on Thursday.

Swaraj had last met Aziz on September 12 at the Shanghai Cooperation Organisation Summit in Dushanbe where the two had exchanged pleasantries during a break at the summit.

"When you are sitting at the same dinner table you have some civilities. We exchanged pleasantries" she said of her meeting in the Tajik capital.

Ahead of participating in the SAARC meeting, Aziz told a group of Indian reporters that an India-Pakistan talks can happen only if New Delhi takes the initiative.

Swaraj said there is no possibility of a meeting between Modi and Sharif.

On being asked that India was upset over Pakistani envoy Abdul Basit's talks with Hurriyat leaders, Aziz said "it was an over-reaction by India."

"Hurriyat talks were nothing new. (Pakistan officials) have been meeting Hurriyat leaders since last 20 years. There will be no initiative from our side. Initiative has to come from India."

On India having concerns over ceasefire violations at the border, Aziz said there were not any violations by Pakistan.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 26,2020

New Delhi, Apr 26: Medical services at Babu Jagjivan Ram Hospital in Jahangirpuri area have been closed and the hospital is being sanitised after 44 staff members including doctors were tested positive for COVID-19, Delhi Health Department said on Saturday.

"Total 44 staff members including doctors at Babu Jagjivan Ram Hospital in Jahangirpuri area of Delhi have tested positive for COVID-19. Test reports of other staff members are awaited. Hospital's medical services have been closed and the hospital is being sanitized," Delhi Health Department said.

Earlier today, Delhi Health Minister Satyendar Jain informed that there are 2,625 coronavirus cases in Delhi, out of which 111 were reported yesterday.

The total number of active cases in the national capital stands at 1,518 while 869 people have recovered so far, the minister further informed. There have been 54 deaths in the national capital, as per the Union Health Ministry.

A total of 26,496 confirmed cases of COVID-19 have been reported in India, including 19,868 active cases, the Ministry of Health and Family Welfare said on Sunday.

824 people have lost their lives due to the infection in the country.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 28,2020

New Delhi, May 28: With 6,566 more coronavirus cases and 194 deaths reported in the past 24 hours, India's COVID-19 tally reached 1,58,333 on Thursday, according to the Union Ministry of Health and Family Affairs.

The number of active coronavirus cases stands at 86,110, while 67,692 people have recovered and one patient has migrated, it said. The death toll due to the infection has reached 4,531 in the country.

Maharashtra is the worst affected state with 56,948 cases. Tamil Nadu has recorded as many as 18,545 cases while Gujarat and Delhi have recorded 15,195 and 15,257 coronavirus cases respectively.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.